Article quotes ISMP experts and summarizes ISMP alerts on errors with investigational use of remdesivir for COVID-19 patients, potential for overdoses with recently approved 2% propofol product, and updated vincristine labeling and packaging.
For the full text, visit Pharmacy Today online.
More News
ECRI and ISMP speak up for patient safety and health workers worldwide with free COVID-19 resources and safety guidance.
One Nurse’s Experience Highlights Need to Focus on Error Identification and Prevention
Together, ECRI and ISMP PSO create one of the largest patient safety entities in the world with unparalleled and trusted expertise to keep patients safer